Literature DB >> 9142835

Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells.

E Papadimitriou1, V G Manolopoulos, G T Hayman, M E Maragoudakis, B R Unsworth, J W Fenton, P I Lelkes.   

Abstract

We have identified a novel cellular action of thrombin on cultured rat adrenal medullary endothelial cells (RAMEC). Five-minute incubation of RAMEC with physiological concentrations of thrombin (<1 U/ml) caused within 3 h an increase in the basolateral deposition of the extracellular matrix (ECM) proteins fibronectin, laminin, and collagens IV and I, concomitant with a corresponding decrease in the apical release of these proteins into the medium. This shift in vectorial secretion of ECM proteins, quantitated with enzyme-linked immunoassays, was time dependent. Maximal stimulation of ECM protein deposition was observed after incubation of cells with thrombin for 5-15 min. Prolonged exposure (>1 h) to thrombin resulted in loss of proteins from the ECM. Thrombin-stimulated ECM protein deposition exhibited a bell-shaped dose dependence, peaking for all proteins at 0.25 U/ml of thrombin, and was independent of de novo mRNA or protein synthesis. Maximal amounts of deposited proteins increased between 2.5-fold (fibronectin) and 4-fold (collagen I) over baseline values. Similar results were obtained with thrombin receptor agonist peptide (TRAP), proteolytically active gamma-thrombin, and, to a lesser extent, other serine proteases such as trypsin and plasmin. A scrambled TRAP, proteolytically inactive PPACK-thrombin, DIP-thrombin, and type IV collagenase were ineffective. Together, these results suggest that the thrombin effects are mediated by proteolytic activation of the thrombin receptor. Possible involvement of the phospholipase C-signaling pathway in thrombin-mediated ECM protein deposition was also investigated. Inhibition or downregulation of protein kinase C (PKC) and chelation of intracellular or extracellular Ca2+ did not suppress, but rather enhanced, basal and thrombin-stimulated ECM protein deposition. Quantitative differences in augmentation of basolateral deposition by these treatments suggest differential regulatory pathways for individual ECM proteins. Our data indicate that, in cultured RAMEC, short-term activation of the thrombin receptor causes an increase in amounts of deposited ECM protein by a cellular signaling pathway that is independent of PKC activation and/or elevation of intracellular Ca2+.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142835     DOI: 10.1152/ajpcell.1997.272.4.C1112

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Dabigatran abrogates brain endothelial cell permeability in response to thrombin.

Authors:  Brian Thomas Hawkins; Yu-Huan Gu; Yoshikane Izawa; Gregory John del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

2.  Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways.

Authors:  Anat Erdreich-Epstein; Linda B Tran; Orla T Cox; Elaine Y Huang; Walter E Laug; Hiroyuki Shimada; Melissa Millard
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

3.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

Review 4.  Progress in the understanding of protease-activated receptors.

Authors:  Esteban C Gabazza; Osamu Taguchi; Haruhito Kamada; Tatsuya Hayashi; Yukihiko Adachi; Koji Suzuki
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

5.  Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity.

Authors:  P-J Yu; G Ferrari; L Pirelli; A C Galloway; P Mignatti; G Pintucci
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

6.  Protein targets of inflammatory serine proteases and cardiovascular disease.

Authors:  Ram Sharony; Pey-Jen Yu; Joy Park; Aubrey C Galloway; Paolo Mignatti; Giuseppe Pintucci
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

Review 7.  Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease.

Authors:  J Levy
Journal:  Endocrine       Date:  1999-02       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.